WallStreetZenWallStreetZen

NASDAQ: GTBP
Gt Biopharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Gt Biopharma earnings were -$58.4M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest GTBP earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$3.4M, down 88.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GTBP reported annual earnings of -$34.4M, with 161.7% growth. The next GTBP earnings date is Aug 13, 2026.

GTBP earnings history

Current Revenue
$0.0
Current Earnings
-$58.4M
Current Profit Margin
0%

GTBP Return on Equity

Current Company
N/A
Current Industry
-141.9%
Current Market
13.5%
GTBP's Return on Equity (-1,215.4%)... subscribe to Premium to read more.
High Return on Equity Performance

GTBP Return on Assets

Current Company
-790.9%
Current Industry
-13.7%
GTBP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GTBP announces earnings.

GTBP Return on Capital Employed

Current Company
-627.23%
Current Industry
-9.6%
GTBP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GTBP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GTBP-$47.54M-$58.42MN/A-$14.83
INAB-$16.65M-$18.98MN/A-$2.61
PHIO-$10.93M-$10.93MN/A-$1.38
XCUR-$9.96M-$9.78MN/A-$1.55
LNAI-$127.62M-$128.28MN/A-$60.80
View Top Biotech Stocks

GTBP earnings dates

Next earnings date
Aug 13, 2026

Gt Biopharma Earnings Reports & History FAQ

What were Gt Biopharma's earnings last quarter?

Gt Biopharma (NASDAQ: GTBP) reported Q1 2026 earnings per share (EPS) of -$0.11, up 66.67% year over year. Total GTBP earnings for the quarter were -$3.37 million. In the same quarter last year, Gt Biopharma's earnings per share (EPS) was -$0.33.

If you're new to stock investing, here's how to buy Gt Biopharma stock.

When does Gt Biopharma report earnings?

The next GTBP earnings call is Aug 13, 2026. Add GTBP to your watchlist to be reminded of Gt Biopharma's next earnings date.

Is Gt Biopharma profitable or losing money?

As of the last Gt Biopharma earnings report, Gt Biopharma is currently losing money. Gt Biopharma's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$47.73 million, a 308.96% increase year over year.

What was GTBP's earnings growth in the past year?

As of Gt Biopharma's earnings date in Q3 2026, Gt Biopharma's earnings has grown year over year. GTBP earnings in the past year totalled -$58.42 million.

What are Gt Biopharma's earnings expectations?

The current EPS estimate for Gt Biopharma's earnings report in Aug 13, 2026 is -$0.08.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.